{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:20:03Z","timestamp":1790083203049,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medical Research Future Fund","award":["APP1175567"],"award-info":[{"award-number":["APP1175567"]}]},{"name":"Medical Research Future Fund","award":["APP1175567"],"award-info":[{"award-number":["APP1175567"]}]},{"name":"Medical Research Future Fund","award":["APP1175567"],"award-info":[{"award-number":["APP1175567"]}]},{"name":"Medical Research Future Fund","award":["APP1175567"],"award-info":[{"award-number":["APP1175567"]}]},{"name":"Medical Research Future Fund","award":["APP1175567"],"award-info":[{"award-number":["APP1175567"]}]},{"name":"Medical Research Future Fund","award":["APP1175567"],"award-info":[{"award-number":["APP1175567"]}]},{"name":"Medical Research Future Fund","award":["APP1175567"],"award-info":[{"award-number":["APP1175567"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>With the high burden of Metabolic dysfunction-associated steatotic liver disease (MASLD), (previously known as Non-Alcoholic Fatty Liver Disease - NAFLD) in the community, current models of care that require specialist review for disease risk stratification overwhelm hospital clinic capacity and create inefficiencies in care. The LOCal Assessment and Triage Evaluation of Non-Alcoholic Fatty Liver Disease (LOCATE-NAFLD) randomised trial compared usual care to a community-based nurse delivered liver risk assessment. This study evaluates the implementation strategy of the LOCATE model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The evaluation used mixed methods (quantitative trial data and qualitative framework analysis of semi-structured interviews) to explore the general practitioner (GP) and patient perspectives of acceptability (Acceptability Framework), and factors associated with reach, effectiveness, adoption, implementation, and maintenance (RE-AIM framework) of the LOCATE model of care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The LOCATE model was considered highly acceptable by both patients and GPs. The model of care achieved appropriate reach across the participating health services, reaching high-risk patients faster than usual care and with predominantly positive patient experiences. A notable reduction in anxiety and stress was experienced in the intervention group due to the shorter waiting times between referral and assessment. There was an overall perception of confidence in nursing staff capability to perform the community-based screening and GPs indicated confidence in managing low-risk MASLD without the need for specialist review. Challenges to implementation, adoption and maintenance included variable prioritisation of liver disease assessment in complex cases, the need for further GP training in MASLD assessment and treatment pathways, available funding and referral pathways for community screening, and accessibility of effective diet and exercise professional support.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Nurse delivered community-based liver screening is highly acceptable to GPs and patients and has shown to be an effective mechanism to identify high risk patients. Adoption and maintenance of the model of care faces significant challenges related to affordable access to screening, prioritisation of liver disease in complex patient cohorts, and unresolved difficulties in prescribing effective strategies for sustained lifestyle intervention in the primary care setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>The trial was registered on 30 January 2020 and can be found via Australian New Zealand Clinical Trials Registry (ANZCTR)\u00a0\u2013 ACTRN12620000158965.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12913-025-12580-5","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T06:52:19Z","timestamp":1742626339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Implementation of a nurse-delivered, community-based liver screening and assessment program for people with metabolic dysfunction-associated steatotic liver disease (LOCATE-NAFLD trial)"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2178-4054","authenticated-orcid":false,"given":"Michelle J.","family":"Allen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Tulleners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6612-348X","authenticated-orcid":false,"given":"David","family":"Brain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3400-2816","authenticated-orcid":false,"given":"James","family":"O\u2019Beirne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5008-8061","authenticated-orcid":false,"given":"Elizabeth E.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6339-0374","authenticated-orcid":false,"given":"Adrian","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8823-3006","authenticated-orcid":false,"given":"Patricia C.","family":"Valery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5650-154X","authenticated-orcid":false,"given":"Sanjeewa","family":"Kularatna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3205-9165","authenticated-orcid":false,"given":"Ingrid J.","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"issue":"10258","key":"12580_CR1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u201322.","journal-title":"Lancet"},{"issue":"12","key":"12580_CR2","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","volume":"20","author":"MH Le","year":"2022","unstructured":"Le MH, Yeo YH, Li X, Li J, Zou B, Wu Y, et al. 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2022;20(12):2809\u2013e1728.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"12580_CR3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-019-0212-0","volume":"17","author":"M Eslam","year":"2020","unstructured":"Eslam M, George J. Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology. Nat Reviews Gastroenterol Hepatol. 2020;17(1):40\u201352.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"10290","key":"12580_CR4","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324.","journal-title":"Lancet"},{"issue":"10","key":"12580_CR5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41575-021-00477-7","volume":"18","author":"JV Lazarus","year":"2021","unstructured":"Lazarus JV, Anstee QM, Hagstr\u00f6m H, Cusi K, Cortez-Pinto H, Mark HE, et al. Defining comprehensive models of care for NAFLD. Nat Rev Gastroenterol Hepatol. 2021;18(10):717\u201329.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"12580_CR6","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Blissett D, Blissett R, Henry L, Stepanova M, Younossi Y, et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016;64(5):1577\u201386.","journal-title":"Hepatology"},{"issue":"1","key":"12580_CR7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12913-020-05233-2","volume":"20","author":"D Brain","year":"2020","unstructured":"Brain D, O\u2019Beirne J, Hickman IJ, Powell EE, Valery PC, Kularatna S, et al. Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD). BMC Health Serv Res. 2020;20(1):335.","journal-title":"BMC Health Serv Res"},{"key":"12580_CR8","first-page":"0","volume-title":"Evaluating Health Promotion: Practice and Methods","author":"D Ellard","year":"2010","unstructured":"Ellard D, Parsons S. 87Process evaluation: understanding how and why interventions work. In: Thorogood M, Coombes Y, editors. Evaluating Health Promotion: Practice and Methods. Oxford University Press; 2010. p. 0."},{"key":"12580_CR9","first-page":"004695801986125","volume":"56","author":"T Willmeroth","year":"2019","unstructured":"Willmeroth T, Wesselborg B, Kuske S. Implementation Outcomes and Indicators as a New Challenge in Health Services Research: A Systematic Scoping Review. Inquiry. 2019;56:0046958019861257.","journal-title":"Inquiry"},{"issue":"2","key":"12580_CR10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","volume":"38","author":"E Proctor","year":"2011","unstructured":"Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for Implementation Research: Conceptual Distinctions, Measurement Challenges, and Research Agenda. Adm Policy Mental Health Mental Health Serv Res. 2011;38(2):65\u201376.","journal-title":"Adm Policy Mental Health Mental Health Serv Res"},{"key":"12580_CR11","doi-asserted-by":"crossref","unstructured":"Tulleners R, Barnett A, O\u2019Beirne J, Powell E, Hickman I, Valery P, Kularatna S, Stuart K, McIvor C, Witness E, Aikebuse M. Brain, D. A parallel randomised trial testing community fibrosis assessment for suspected non-alcoholic fatty liver disease: Outcomes from LOCATE-NAFLD. 2024.","DOI":"10.21203\/rs.3.rs-3960262\/v1"},{"key":"12580_CR12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fpubh.2019.00064","volume":"7","author":"RE Glasgow","year":"2019","unstructured":"Glasgow RE, Harden SM, Gaglio B, Rabin B, Smith ML, Porter GC, et al. RE-AIM Planning and Evaluation Framework: Adapting to New Science and Practice With a 20-Year Review. Front Public Health. 2019;7:64.","journal-title":"Front Public Health"},{"issue":"9","key":"12580_CR13","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2105\/AJPH.89.9.1322","volume":"89","author":"RE Glasgow","year":"1999","unstructured":"Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89(9):1322\u20137.","journal-title":"Am J Public Health"},{"issue":"6","key":"12580_CR14","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.2105\/AJPH.2013.301299","volume":"103","author":"B Gaglio","year":"2013","unstructured":"Gaglio B, Shoup JA, Glasgow RE. The RE-AIM framework: a systematic review of use over time. Am J Public Health. 2013;103(6):e38\u201346.","journal-title":"Am J Public Health"},{"issue":"1","key":"12580_CR15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12913-017-2031-8","volume":"17","author":"M Sekhon","year":"2017","unstructured":"Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res. 2017;17(1):88.","journal-title":"BMC Health Serv Res"},{"key":"12580_CR16","unstructured":"Australian Government. Modified Monash Model. In: Department of Health and Aged Care, Australian Goverment. 2023. https:\/\/www.health.gov.au\/topics\/rural-health-workforce\/classifications\/mmm."},{"key":"12580_CR17","unstructured":"Kobakian SCD. Sugarbag: Create Hexagon Tile Maps. 2019. Available from:\u00a0https:\/\/srkobakian.github.io\/sugarbag\/."},{"key":"12580_CR18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2288-13-117","volume":"13","author":"NK Gale","year":"2013","unstructured":"Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13:117.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"12580_CR19","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1186\/s12913-023-09934-2","volume":"23","author":"MJ Allen","year":"2023","unstructured":"Allen MJ, Doran R, Brain D, Powell EE, O\u2019Beirne J, Valery PC, et al. A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levels. BMC Health Serv Res. 2023;23(1):950.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"12580_CR20","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2023.04.035","volume":"79","author":"JV Lazarus","year":"2023","unstructured":"Lazarus JV, Mark HE, Allen AM, Arab JP, Carrieri P, Noureddin M, et al. A global research priority agenda to advance public health responses to fatty liver disease. J Hepatol. 2023;79(3):618\u201334.","journal-title":"J Hepatol"},{"issue":"11","key":"12580_CR21","doi-asserted-by":"crossref","first-page":"e041574","DOI":"10.1136\/bmjopen-2020-041574","volume":"10","author":"H Knight","year":"2020","unstructured":"Knight H, Harman D, Morling JR, Aithal G, Card T, Guha IN, Bains M. Acceptability of chronic liver disease screening in a UK primary care setting: a qualitative evaluation. BMJ Open. 2020;10(11):e041574.","journal-title":"BMJ Open"},{"issue":"10","key":"12580_CR22","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.drugpo.2015.07.002","volume":"26","author":"AD Marshall","year":"2015","unstructured":"Marshall AD, Micallef M, Erratt A, Telenta J, Treloar C, Everingham H, et al. Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study. Int J Drug Policy. 2015;26(10):984\u201391.","journal-title":"Int J Drug Policy"},{"issue":"8","key":"12580_CR23","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1111\/liv.15941","volume":"44","author":"EA Tsochatzis","year":"2024","unstructured":"Tsochatzis EA, Valenti L, Thiele M, P\u00e9loquin S, Lazure P, Masson MH, et al. Use of non-invasive diagnostic tools for metabolic dysfunction-associated steatohepatitis: A qualitative exploration of challenges and barriers. Liver Int. 2024;44(8):1990\u20132001.","journal-title":"Liver Int"},{"issue":"6","key":"12580_CR24","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/acr.25037","volume":"75","author":"DJ Hunter","year":"2023","unstructured":"Hunter DJ, Bowden JL, Hinman RS, Egerton T, Briggs AM, Bunker SJ, et al. Effectiveness of a New Service Delivery Model for Management of Knee Osteoarthritis in Primary Care: A Cluster Randomized Controlled Trial. Arthritis Care Res (Hoboken). 2023;75(6):1320\u201332.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"12580_CR25","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/tbm\/ibz080","volume":"10","author":"K Hallsworth","year":"2020","unstructured":"Hallsworth K, Dombrowski SU, McPherson S, Anstee QM, Avery L. Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study. Transl Behav Med. 2020;10(4):1016\u201330.","journal-title":"Transl Behav Med"},{"issue":"6","key":"12580_CR26","doi-asserted-by":"crossref","first-page":"e14799","DOI":"10.1111\/dme.14799","volume":"39","author":"L Gracen","year":"2022","unstructured":"Gracen L, Hayward KL, Aikebuse M, Williams S, Russell A, O\u2019Beirne J, et al. An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care. Diabet Med. 2022;39(6):e14799.","journal-title":"Diabet Med"},{"issue":"676","key":"12580_CR27","doi-asserted-by":"crossref","first-page":"e743","DOI":"10.3399\/bjgp18X699377","volume":"68","author":"HC Standing","year":"2018","unstructured":"Standing HC, Jarvis H, Orr J, Exley C, Hudson M, Kaner E, Hanratty B. GPs\u2019 experiences and perceptions of early detection of liver disease: a qualitative study in primary care. Br J Gen Pract. 2018;68(676):e743\u20139.","journal-title":"Br J Gen Pract"},{"issue":"7","key":"12580_CR28","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/ueg2.12445","volume":"11","author":"S Driessen","year":"2023","unstructured":"Driessen S, de Jong VD, van Son KC, Klompenhouwer T, Colardelle Y, Alings M, et al. A global survey of health care workers\u2019 awareness of non-alcoholic fatty liver disease: The AwareNASH survey. United Eur Gastroenterol J. 2023;11(7):654\u201362.","journal-title":"United Eur Gastroenterol J"},{"issue":"3","key":"12580_CR29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/gut.2003.027581","volume":"53","author":"IJ Hickman","year":"2004","unstructured":"Hickman IJ, Jonsson JR, Prins JB, Ash S, Purdie DM, Clouston AD, Powell EE. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut. 2004;53(3):413\u20139.","journal-title":"Gut"},{"issue":"6","key":"12580_CR30","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jhepr.2019.10.008","volume":"1","author":"K Hallsworth","year":"2019","unstructured":"Hallsworth K, Adams LA. Lifestyle modification in NAFLD\/NASH: Facts and figures. JHEP Rep. 2019;1(6):468\u201379.","journal-title":"JHEP Rep"},{"issue":"12","key":"12580_CR31","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1007\/s40279-023-01918-w","volume":"53","author":"SE Keating","year":"2023","unstructured":"Keating SE, Sabag A, Hallsworth K, Hickman IJ, Macdonald GA, Stine JG, et al. Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia. Sports Med. 2023;53(12):2347\u201371.","journal-title":"Sports Med"},{"issue":"6","key":"12580_CR32","doi-asserted-by":"crossref","first-page":"e014999","DOI":"10.1136\/bmjopen-2016-014999","volume":"7","author":"E Cottrell","year":"2017","unstructured":"Cottrell E, Foster NE, Porcheret M, Rathod T, Roddy E. GPs\u2019 attitudes, beliefs and behaviours regarding exercise for chronic knee pain: a questionnaire survey. BMJ Open. 2017;7(6):e014999.","journal-title":"BMJ Open"},{"issue":"1","key":"12580_CR33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41371-018-0098-2","volume":"33","author":"BJ Smith","year":"2019","unstructured":"Smith BJ, Owen AJ, Liew D, Kelly DJ, Reid CM. Prescription of physical activity in the management of high blood pressure in Australian general practices. J Hum Hypertens. 2019;33(1):50\u20136.","journal-title":"J Hum Hypertens"},{"issue":"4","key":"12580_CR34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/ppc.12088","volume":"51","author":"R Stanton","year":"2015","unstructured":"Stanton R, Franck C, Reaburn P, Happell B. A Pilot Study of the Views of General Practitioners Regarding Exercise for the Treatment of Depression. Perspect Psychiatr Care. 2015;51(4):253\u20139.","journal-title":"Perspect Psychiatr Care"},{"key":"12580_CR35","doi-asserted-by":"crossref","unstructured":"Arora C, Malhotra A, Ranjan P, Vikram NK, Dwivedi SN, Singh N, Shalimar. Perceived barriers and facilitators for adherence to lifestyle prescription: Perspective of obese patients with non alcoholic fatty liver disease from north India. Diabetes Metab Syndr. 2021;15(4):102138.","DOI":"10.1016\/j.dsx.2021.05.011"},{"key":"12580_CR36","doi-asserted-by":"crossref","first-page":"348293","DOI":"10.1155\/2011\/348293","volume":"2011","author":"R Dalle Grave","year":"2011","unstructured":"Dalle Grave R, Calugi S, Centis E, El Ghoch M, Marchesini G. Cognitive-behavioral strategies to increase the adherence to exercise in the management of obesity. J Obes. 2011;2011:348293.","journal-title":"J Obes"},{"key":"12580_CR37","doi-asserted-by":"crossref","unstructured":"Schmidt SK, Hemmestad L, MacDonald CS, Langberg H, Valentiner LS. Motivation and Barriers to Maintaining Lifestyle Changes in Patients with Type 2 Diabetes after an Intensive Lifestyle Intervention (The U-TURN Trial): A Longitudinal Qualitative Study. Int J Environ Res Public Health. 2020; 17(20):7454.","DOI":"10.3390\/ijerph17207454"},{"issue":"7","key":"12580_CR38","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2337\/diacare.25.7.1159","volume":"25","author":"SL Norris","year":"2002","unstructured":"Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care. 2002;25(7):1159\u201371.","journal-title":"Diabetes Care"},{"issue":"1","key":"12580_CR39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12966-023-01424-2","volume":"20","author":"AL Deslippe","year":"2023","unstructured":"Deslippe AL, Soanes A, Bouchaud CC, Beckenstein H, Slim M, Plourde H, Cohen TR. Barriers and facilitators to diet, physical activity and lifestyle behavior intervention adherence: a qualitative systematic review of the literature. Int J Behav Nutr Phys Activity. 2023;20(1):14.","journal-title":"Int J Behav Nutr Phys Activity"},{"issue":"10","key":"12580_CR40","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1007\/s10620-020-06673-w","volume":"66","author":"JG Stine","year":"2021","unstructured":"Stine JG, Soriano C, Schreibman I, Rivas G, Hummer B, Yoo E, et al. Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease. Dig Dis Sci. 2021;66(10):3604\u201311.","journal-title":"Dig Dis Sci"},{"issue":"7","key":"12580_CR41","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.cgh.2018.10.044","volume":"17","author":"L Haigh","year":"2019","unstructured":"Haigh L, Bremner S, Houghton D, Henderson E, Avery L, Hardy T, et al. Barriers and Facilitators to Mediterranean Diet Adoption by Patients With Nonalcoholic Fatty Liver Disease in Northern Europe. Clin Gastroenterol Hepatol. 2019;17(7):1364\u2013e713.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"12580_CR42","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/fampra\/cms025","volume":"29","author":"L Ball","year":"2012","unstructured":"Ball L, Hughes R, Desbrow B, Leveritt M. Patients\u2019 perceptions of nutrition care provided by general practitioners: focus on Type 2 diabetes. Fam Pract. 2012;29(6):719\u201325.","journal-title":"Fam Pract"},{"issue":"5","key":"12580_CR43","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.amjmed.2020.01.007","volume":"133","author":"J Budd","year":"2020","unstructured":"Budd J, Cusi K. Nonalcoholic Fatty Liver Disease: What Does the Primary Care Physician Need to Know? Am J Med. 2020;133(5):536\u201343.","journal-title":"Am J Med"},{"issue":"9","key":"12580_CR44","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.clnu.2022.06.037","volume":"41","author":"L Haigh","year":"2022","unstructured":"Haigh L, Kirk C, El Gendy K, Gallacher J, Errington L, Mathers JC, Anstee QM. The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis. Clin Nutr. 2022;41(9):1913\u201331.","journal-title":"Clin Nutr"},{"key":"12580_CR45","doi-asserted-by":"crossref","first-page":"e37487","DOI":"10.2196\/37487","volume":"25","author":"OY Kwon","year":"2023","unstructured":"Kwon OY, Choi J-y, Jang Y. The Effectiveness of eHealth Interventions on Lifestyle Modification in Patients With Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-analysis. J Med Internet Res. 2023;25:e37487.","journal-title":"J Med Internet Res"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-12580-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-12580-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-12580-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T06:53:28Z","timestamp":1742626408000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-12580-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12580"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-12580-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4352928\/v1","asserted-by":"object"}]},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,22]]},"assertion":[{"value":"1 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was granted by the Royal Brisbane and Women\u2019s Hospital Human Research Ethics Committee, reference number HREC\/2020\/QRBW\/60855. Participant consent was obtained in writing.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants providing individual consent to participate, also provided consent to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"421"}}